Oral Cancer News | Tag Archive

Viruses recruited as killers of tumors

Tuesday, March 20, 2012

Source: nytimes.com Author: Rachel Nuwer In 1951, a 4-year-old boy with leukemia contracted chickenpox. His liver and spleen, swollen by the cancer, soon returned to normal, and his elevated blood cell count fell to that of a healthy child. His doctors at the Laboratory of Experimental Oncology in San Francisco were thrilled by his sudden [...]

Canadian provinces weighing HPV vaccination of boys

Sunday, February 26, 2012

0 Comments

Source: www.cmaj.ca/ Author: Laura Eggertson Provinces weighing the merits of implementing the National Advisory Committee on Immunization’s recommendation to offer human papillomavirus (HPV) vaccine to boys and men aged 9–26 are facing a tricky trade-off between benefits and costs. “I think the benefits are there, but the costs are high,” which is a crucial issue [...]

HPV Connected to Oral Cancers Too

Wednesday, February 15, 2012

0 Comments

Source: Chicago Tribune It’s common knowledge that HPV — or human papillomavirus — is linked with cervical cancer, thanks to the controversy over the vaccine. But far fewer people know that this same sexually transmitted viral strain is connected to oral cancers, according to a new study, recently published in the Journal of the American [...]

HPV a gender-neutral killer

Wednesday, February 15, 2012

0 Comments

Source: DailyPress.com Socially conservative lawmakers will likely repeal Virginia’s requirement that schoolgirls get vaccinated against a sexually transmitted virus called HPV that can, and now will, kill many of them. They’re repealing it in the name of sexual abstinence, family values and apple pie. In the name of keeping government out of private health-care decisions [...]

Success of HPV vaccination is now a matter of coverage

Wednesday, January 4, 2012

0 Comments

Source: The Lancet Oncology, Volume 13, Issue 1, Pages 10-12, January 2012 In a pair of articles in The Lancet Oncology, Lehtinen and colleagues and Wheeler and colleagues present 4-year end of study data from a trial of a prophylactic human papillomavirus (HPV)-16/-18 vaccine (Cervarix, GlaxoSmithKline) in young women aged 15-25 years. From a public-health [...]

Preventing Cancer with Vaccines: Progress in the Global Control of Cancer

Wednesday, January 4, 2012

0 Comments

Source: CancerPreventionResearch.AACJournals.org Abstract The cancer control community is largely unaware of great advances in the control of major human cancers with vaccines, including the dramatic control of hepatocellular (liver) cancer with hepatitis B virus (HBV) vaccine, now used routinely in more than 90% of countries. The biotechnology revolution has given us a new generation of [...]

Study Endorses HPV Testing for All Women Over 30

Tuesday, December 27, 2011

0 Comments

Source: Medscape.com LONDON (Reuters) Dec 15 – New DNA tests looking for the virus responsible for most cases of cervical cancer make sense for all women aged 30 or over, since they can prevent more cases of cancer than Pap smears alone, Dutch researchers say. Results of a five-year study involving 45,000 women provided the [...]

UI professors: HPV editorial misses the mark

Thursday, December 8, 2011

1 Comment

Source: The Daily Iowan The Nov. 29 editorial “Recommend Pap smears, not vaccines, to prevent cervical cancer” completely missed the mark with regard to HPV vaccines. We are researchers and clinicians at the University of Iowa who study and treat HPV and other infectious diseases. It is disturbing to think that the article might dissuade [...]

HPV vaccine myths put health, lives at risk, say health leaders: Airing the facts

Thursday, December 1, 2011

0 Comments

Source: TheNationsHealth.org Vaccination rates for human papillomavirus are lagging for teens, and a complicated web of confusion and misinformation may be to blame, according to public health leaders. Several strains of HPV can cause cervical cancer, and two vaccines, Gardasil and Cervarix, have been shown conclusively to defend against those strains. The Food and Drug [...]

Use and Acceptance of HPV Vaccine Still a Work in Progress

Wednesday, November 30, 2011

0 Comments

Source: National Cancer Institute A bellwether moment in the history of cancer prevention came in 2006 when the Food and Drug Administration (FDA) approved the first vaccine to prevent cervical cancer. The vaccine, Gardasil, protects against the two primary cancer-causing, or oncogenic, types of the human papillomavirus (HPV)—HPV-16 and HPV-18. These types are responsible for [...]

Tag Archive | "cervical cancer"